BiondVax edges closer to elusive universal flu vaccine
Every year, seasonal influenza causes about 290,000 to 650,000 respiratory deaths, and a further three to five million cases of severe illness.
BiondVax CEO Dr. Ron Babecoff (upper row, center) and employees at the company's new Jerusalem production facility(photo credit: Courtesy)ByEYTAN HALON